News of the index components STOXX Europe 600 Index (EUR)

Index

SXXP

EU0009658202

Market Closed - Switzerland 11:50:00 2026-01-16 EST			5-day change	1st Jan Change
614.38 ^PTS	-0.03%		+0.77%	+3.75%

12-31	European Equities Traded in the US as American Depositary Receipts Decline Wednesday	MT
12-31	Blue-chip FTSE 100 stalls near record high, sealing strongest annual run in 16 years	RE

News of the index components

08:17am	Auto Industry Warns of Consequences from Trump's New Tariffs	DP
05:49am	Bayer Receives EU Approval for High-Dose Eylea in Another Indication	DP
03:57am	Indonesia finds wreckage of missing surveillance plane carrying 10, one body	RE
02:47am	Shell, Mitsubishi Reportedly Eye Offloading Stakes in Canadian LNG Project	MT
01:02am	Shell, Mitsubishi Reportedly Eye Offloading Stakes in Canadian LNG Project	MT
12:36am	Novartis Lands US FDA Breakthrough Therapy Classification for Ianalumab in Sjögren's Disease	MT
10:37pm	Indonesian authorities find wreckage of missing surveillance plane with 11 on board	RE
01-17	Almost All Brands Significantly Reduce CO2 Emissions in Germany	DP
01-17	Indonesia searching for missing surveillance plane with 11 onboard	RE
01-17	ATR says aware of ATR 42-500 accident in Indonesia, assisting probe	RE
01-16	Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup	DJ
01-16	Sector Update: Health Care Stocks Retreat Late Afternoon	MT
01-16	JERA Nex BP to buy EnBW's stake in UK's Mona offshore wind project	RE
01-16	Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation	RE
01-16	Bayer AG - Company expects a decision on merits during court's 2026 session, which ends in June	RE
01-16	Bayer AG - U.S. Supreme Court today announced that it will review Durnell Roundup case	RE
01-16	The Pressure on Memory Chips	MT
01-16	US Supreme Court to hear Bayer's bid to curb Roundup cases	RE
01-16	U.S. Supreme Court agrees to hear Bayer's bid to limit lawsuits filed under state laws over its weedkiller Roundup	RE
01-16	AbbVie, Genmab Lymphoma Treatment Shows Improved Progression-Free Survival	DJ
01-16	Genmab Says Epcoritamab Improves Progression-Free Survival in Phase 3 Lymphoma Study	MT
01-16	Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study	RE
01-16	Sector Update: Health Care Stocks Softer Friday Afternoon	MT
01-16	Musk and Ryanair CEO clash over cost of Starlink Wi-Fi on planes	RE
01-16	Genmab says phase 3 trial for epcoritamab did not reach statistical significance	RE
01-16	Genmab's blood cancer drug fails main goal in late-stage study	RE
01-16	British Airways pauses flights to Bahrain as precautionary measure	RE
01-16	Genmab Stock Trading Halted, Pending Material News Release	MT
01-16	Novartis Receives US FDA Breakthrough Therapy Designation for Ianalumab to Treat Sjogren's Disease	MT
01-16	European Stocks Close Out Week Lower in Friday Trading; Annual Inflation Rises in Italy	MT
01-16	Copper, AI & America's Supply Risk	MT
01-16	Novartis - Ianalumab receives FDA breakthrough therapy designation for Sjögren's disease	RE
01-16	Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren's disease	DJ
01-16	Michèle Benbunan Appointed Head of LVMH's Media Division
01-16	Novo shares jump on 'encouraging' Wegovy pill scripts data, analysts say	RE
01-16	Diploma CEO Johnny Thomson sells GBP1.7 million in shares	AN
01-16	Bank of Botswana says Standard Chartered exploring sale of Stanchart business in Botswana	RE
01-16	European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Rise 2% for Week	MT
01-16	Ørsted resumes Revolution Wind after court decision
01-16	British Navy unveils first full-size autonomous helicopter	RE